Bristol-Myers Squibb Company (LON:0R1F)

London flag London · Delayed Price · Currency is GBP · Price in USD
55.58
+0.48 (0.88%)
At close: Feb 21, 2025
11.41%
Market Cap 89.62B
Revenue (ttm) 38.58B
Net Income (ttm) -7.15B
Shares Out n/a
EPS (ttm) -3.53
PE Ratio n/a
Forward PE n/a
Dividend 1.90 (3.48%)
Ex-Dividend Date Jan 3, 2025
Volume 6,341
Average Volume 18,554
Open 55.67
Previous Close 55.10
Day's Range 54.86 - 55.68
52-Week Range 57.97 - 81.40
Beta 0.45
RSI 45.44
Earnings Date Feb 6, 2025

About LON:0R1F

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R1F
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.